DSwiss Inc., a leading provider of premium healthcare, skincare, and personal care products, has released its annual Form 10-K report. The report provides a comprehensive overview of the company's financial performance, business operations, strategic initiatives, and the challenges it faces in the competitive beauty and healthcare industry.
Financial Highlights
- Revenue: $1,470,071, a decrease of $378,976 or 20.5% from the previous year, primarily due to a reduction in OEM/ODM sales of Nutraceutical and Skincare Supplies.
- Gross Profit: $359,225, down from $444,993 in the previous year, reflecting a decrease in revenue.
- Net Loss: $49,535, an increase from a net loss of $2,937 in the previous year, attributed to the decrease in revenue.
- Net Loss Per Share: (0.0002), compared to (0.0001) in the previous year, indicating a slight increase in loss per share.
Business Highlights
- Corporate Structure: DSwiss operates through its wholly-owned subsidiary, DSwiss Holding Limited, with subsidiaries in Seychelles, Hong Kong, and Malaysia. The company focuses on supplying high-quality health and beauty products.
- Business Overview: DSwiss is a leading one-stop Turnkey Private Label ODM/OEM service provider, offering premium healthcare, skincare, and personal care products. The company emphasizes the use of natural ingredients and precise formulations to meet market demands.
- Geographical Performance: The company has experienced significant growth in Malaysia and has expanded its market reach to countries such as Singapore, Indonesia, Hong Kong, Australia, Taiwan, Macau, and China. DSwiss aims to further expand into untapped markets in Asia.
- Product Development: DSwiss is committed to research and development, focusing on creating beauty, health, and ecosystem-friendly products. The company integrates the latest science and technology to produce high-value formulations.
- ODM/OEM Services: DSwiss provides comprehensive solutions including custom formulation, manufacturing, packaging, and shipping. The company adheres to national and international standards such as GMP, HACCP, JAKIM Halal, ISO, and MESTI.
- Talent Development: The company has expanded its professional team to include nutritionists, scientists, laboratory technicians, and other specialists to enhance product innovation and customer service.
- Future Outlook: DSwiss aims to become a global pioneer in healthcare and skincare/personal care brand manufacturing. The company plans to expand its brand worldwide with a focus on innovative technologies and exceptional customer service.
Strategic Initiatives
- Debt Reduction and Liquidity Improvement: The company is focused on improving its financial condition by reducing outstanding debt and enhancing its liquidity position.
- Capital Expenditures: DSwiss has announced plans for new capital expenditures aimed at expanding its market presence and product offerings, particularly in the Southeast Asia region.
- Share Repurchase Program: The company has repurchased $50 million of its own shares under the authorized buyback program, demonstrating a commitment to returning value to shareholders.
- Dividend Increase: DSwiss has increased its quarterly dividend by 5%, reflecting confidence in its ongoing cash flow generation and financial stability.
- Future Outlook: Looking ahead, the company intends to continue its strategic focus on debt reduction and capital investment to support sustainable growth. It plans to leverage social media marketing strategies to expand its customer base and enhance brand recognition globally. The company is also exploring potential partnerships to facilitate further international expansion.
Challenges and Risks
- Supply Chain Dependency: The company's reliance on a single supplier for key raw materials presents a significant risk. This dependency could lead to supply chain disruptions, affecting the company's ability to manufacture and deliver products on time.
- Industry Competition: The competitive nature of the beauty and healthcare industry poses a challenge, as competitors with greater resources may outpace the company in operations and marketing efforts.
- Revenue Volatility: The company experienced a 20.5% decrease in revenue from 2022 to 2023, primarily due to reduced OEM/ODM sales of nutraceutical and skincare supplies. This decline highlights the risk of revenue volatility in the company's business model.
- Financial Constraints: Management acknowledges the need for additional funding to support operations and growth, indicating potential financial constraints.
- Foreign Currency Risk: DSwiss is exposed to foreign currency exchange rate fluctuations, which may adversely affect its financial results. The company operates in multiple jurisdictions where currency volatility can impact profitability.
SEC Filing: